--------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
---------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) of the
SECURITIES EXCHANGE ACT OF 1934
Date of earliest event reported: August 29, 2002
WEST PHARMACEUTICAL SERVICES, INC.
--------------------------------------------------
(Exact name of registrant as specified in charter)
Pennsylvania 1-8036 23-1210010
------------------------ ------------------------ ------------------
(State of Incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)
101 Gordon Drive, P.O. Box 645, Lionville, Pennsylvania 19341-0645
-------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(610) 594-2900
--------------
(Registrant's telephone number, including area code)
N/A
-------------------------------------------------------------
(Former name or former address, if changed since last report)
--------------------------------------------------------------------------------
Item 5. Other Events and Regulation FD Disclosure.
West Pharmaceutical Services, Inc. hereby files this Current Report on Form
8-K in order to incorporate by reference the selected financial information
attached hereto as Exhibit 99.1 into our registration on Form S-3 to be
subsequently filed by us on the date hereof in order to provide the disclosures
required by paragraph 61 of Statement of Financial Accounting Standards No. 142,
"Goodwill and Other Intangible Assets" as a result of our filing of our
registration statement.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits:
Exhibit No. Description
99.1 Five-Year Summary for West Pharmaceutical
Services, Inc.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
WEST PHARMACEUTICAL SERVICES, INC.
Date: August 29, 2002 By: /s/ Linda R. Altemus
----------------------------------
Linda R. Altemus
Vice President and
Chief Financial Officer